<p>
    Neuroendocrine Liver Metastases:
</p>
<p>
    Liver transplantation (LT) is a potential curative option for a highly selected subset of patients with liver-only metastases from well-differentiated neuroendocrine tumors (NETs). Given the variability in disease progression and limited prospective data, strict inclusion criteria have been proposed to optimize outcomes.
</p>
<p>
    Eligibility Criteria for LT in NET Patients at UHN
</p>
<ul>
    <li data-list-item-id="ead078ad97c2ac252421f9f1ba39ac862">
         <strong>Age</strong>: &lt;65 years (flexible based on comorbidities and transplant candidacy)
    </li>
    <li data-list-item-id="ea0b73c027a0a084be05578ec93ead3c4">
       <strong> Tumor Differentiation</strong>: Well-differentiated NETs (G1/G2) with Ki-67/MIB ≤10%
    </li>
    <li data-list-item-id="e5b752b70b15074370d16a12cd2850263">
       <strong> Primary Tumor</strong>: Must be resected ≥6 months prior to transplant and drain via the portal venous system
    </li>
    <li data-list-item-id="e733c29c584040f48c2bd49bd9061e28d">
         <strong>Disease Stability</strong>: Must demonstrate stable disease for ≥6 months; patients progressing on first-line therapy should undergo second-line treatment before transplant consideration
    </li>
    <li data-list-item-id="efd0625b7707da503ed3ea002fd39f4ac">
       <strong> Disease Burden</strong>: No volume restriction, but liver disease must be <strong>unresectable</strong>
    </li>
    <li data-list-item-id="ea8d52ac75f2fc127f71d2f80c74ca7f5">
         <strong>Metastasis Location</strong>: Strictly liver-only; no extrahepatic disease confirmed by <strong>Ga68-PET</strong>
    </li>
    <li data-list-item-id="e4e60e3bf8d59c05cb8d9e85f2723ad4d">
         <strong>Treatment History</strong>: No limit on number of systemic/locoregional treatment lines
    </li>
    <li data-list-item-id="e45bd4f945cd03c0b04f7274fdb949a19">
      <strong>Liver Transplant Type</strong>: Both living donor and deceased donor grafts accepted
    </li>
</ul>
<p>
    Evaluation Approach
</p>
<ul>
    <li data-list-item-id="e171466a38944f05378cad636d0e06739">
         Prospective implementation of selection criteria
    </li>
    <li data-list-item-id="e935ae66ed36389803e5abd52dfe0e12e">
         Comparison of outcomes with non-transplanted controls
    </li>
    <li data-list-item-id="e26034150cd71bcaacf0c97195169f42e">
         Collaboration with SEER database for matched cohort analysis&nbsp;
    </li>
</ul>